Literature DB >> 28765050

Role of ubiquitination and proteolysis in the regulation of pro- and anti-apoptotic TNF-R1 signaling.

Jürgen Fritsch1, Philipp Zingler1, Vinzenz Särchen1, Anna Laura Heck1, Stefan Schütze2.   

Abstract

Tumor Necrosis Factor Receptor 1 (TNF-R1) transmits various intracellular signaling cascades leading to diverse biological outcomes, ranging from proliferation, differentiation, survival to the induction of various forms of cell death (i.e. apoptosis, necrosis, necroptosis). These signaling pathways have to be tightly regulated. Proteolysis is an important regulatory mechanism in TNF-R1 pro-apoptotic as well as anti-apoptotic/pro-inflammatory signaling. Some key players in these signaling cascades are known (mainly the caspase-family of proteases and a previously unrecognized "lysosomal death pathway" involving cathepsins), however the interaction of proteases in the regulation of TNF signaling is still enigmatic. Ubiquitination of proteins, both non-degradative degradative, which either results in proteolytic degradation of target substrates or regulates their biological function, represents another layer of regulation in this signaling cascade. We and others found out that the differences in signal quality depend on the localization of the receptors. Plasma membrane resident receptors activate survival signals, while endocytosed receptors can induce cell death. In this article we will review the role of ubiquitination and proteolysis in these diverse events focusing on our own contributions to the lysosomal apoptotic pathway linked to the subcellular compartmentalization of TNF-R1. This article is part of a Special Issue entitled: Proteolysis as a Regulatory Event in Pathophysiology edited by Stefan Rose-John.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Proteolysis; Receptor compartmentalization; TNF; TNF-receptor 1; Ubiquitination

Mesh:

Substances:

Year:  2017        PMID: 28765050     DOI: 10.1016/j.bbamcr.2017.07.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  6 in total

1.  COP9 signalosome complex subunit 5, an IFT20 binding partner, is essential to maintain male germ cell survival and acrosome biogenesis†.

Authors:  Qian Huang; Hong Liu; Jing Zeng; Wei Li; Shiyang Zhang; Ling Zhang; Shizhen Song; Ting Zhou; Miriam Sutovsky; Peter Sutovsky; Ruggero Pardi; Rex A Hess; Zhibing Zhang
Journal:  Biol Reprod       Date:  2020-02-12       Impact factor: 4.285

Review 2.  TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages.

Authors:  Harald Wajant; Daniela Siegmund
Journal:  Front Cell Dev Biol       Date:  2019-05-29

3.  TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS.

Authors:  Cécile Rittore; Déborah Méchin; Elodie Sanchez; Léa Marinèche; Vuthy Ea; Stephan Soler; Marion Vereecke; Aude Mallavialle; Eric Richard; Isabelle Duroux-Richard; Florence Apparailly; Isabelle Touitou; Sylvie Grandemange
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

4.  Genetic polymorphism of ADAM17 and decreased bilirubin levels are associated with allergic march in the Korean population.

Authors:  Jaemee Jung; Dahyun Hwang
Journal:  BMC Med Genomics       Date:  2022-02-07       Impact factor: 3.063

5.  Roles for ADAM17 in TNF-R1 Mediated Cell Death and Survival in Human U937 and Jurkat Cells.

Authors:  Jürgen Fritsch; Julia Frankenheim; Lothar Marischen; Timea Vadasz; Anja Troeger; Stefan Rose-John; Dirk Schmidt-Arras; Wulf Schneider-Brachert
Journal:  Cells       Date:  2021-11-10       Impact factor: 6.600

6.  Palmitoylation is required for TNF-R1 signaling.

Authors:  Philipp Zingler; Vinzenz Särchen; Timo Glatter; Lotta Caning; Carina Saggau; Rahul S Kathayat; Bryan C Dickinson; Dieter Adam; Wulf Schneider-Brachert; Stefan Schütze; Jürgen Fritsch
Journal:  Cell Commun Signal       Date:  2019-08-05       Impact factor: 5.712

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.